We keep an eye out for the most interesting stories about Labby subjects: digital media, startups, the web, journalism, strategy, and more. Here’s some of what we’ve seen lately.

I am often asked how long I have worked at Princeton University Press. When I respond, “37 years,” the reaction is sometimes ...

Artificial intelligence is pushing the publishing world toward volume. That could drown out the good work. AI has the power ...

Pro-life scholars and Sage Publications continue to battle over retracted articles. Dr. James Studnicki and his fellow authors sued Sage Publications to compel arbitration after the publishing company ...

Following the decision that eLife will not receive an Impact Factor in 2025, we share an update on how our model is doing ...

An investor group with big wallets is making a $70 million bet on life science startups, and there’s a big Triangle tie.

Faculty of Life and Health Sciences As a leading provider of health-related education, with almost 6,500 students and approximately 250 academic staff, we offer an extensive portfolio of accredited ...

With Donald Trump now confirmed as the President-elect, the life sciences industry is bracing for significant policy shifts that could impact everything from drug pricing to regulatory practices.

Science sleuths work tirelessly to uncover ... Already, an arms race is emerging as integrity specialists, publishers and technology companies race to develop AI tools that can assist in rapidly ...

Clone Robotics did not respond to questions from Live Science about the materials used in the torso and about whether the company is planning to further extend the design into a full roboticized body.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in ...